Detalhe da pesquisa
1.
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
Cancer
; 130(6): 876-885, 2024 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985359
2.
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood
; 140(5): 504-515, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35512184
3.
Lenalidomide in follicular lymphoma.
Blood
; 135(24): 2133-2136, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236519
4.
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Haematologica
; 107(3): 690-701, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792219
5.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184451
6.
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma.
Haematologica
; 106(10): 2667-2672, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732355
7.
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.
Br J Haematol
; 189(4): 650-660, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32180219
8.
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Haematologica
; 105(7): 1907-1913, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601688
9.
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Br J Haematol
; 185(5): 874-882, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919940
10.
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 130(4): 472-477, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522441
11.
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Ann Hematol
; 98(5): 1169-1176, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617643
12.
Idelalisib in the management of lymphoma.
Blood
; 128(3): 331-6, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27252232
13.
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Blood
; 137(8): 1124-1129, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32932518
14.
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Br J Haematol
; 177(2): 263-270, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28340281
15.
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Br J Haematol
; 176(5): 750-758, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983760
16.
Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
Ophthalmic Plast Reconstr Surg
; 33(5): 355-360, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27636243
17.
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Cancer
; 122(20): 3145-3151, 2016 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351173
18.
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ß2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Br J Haematol
; 175(2): 290-299, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27448187
19.
Role of the tumor microenvironment in mature B-cell lymphoid malignancies.
Haematologica
; 101(5): 531-40, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132279
20.
Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.
Br J Haematol
; 171(4): 509-16, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260306